CIBC Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-122,620
Closed -$1.47M 1214
2024
Q2
$1.47M Sell
122,620
-51,626
-30% -$577K 0.01% 616
2024
Q1
$1.93M Hold
174,246
0.01% 582
2023
Q4
$1.51M Hold
174,246
0.01% 604
2023
Q3
$1.33M Hold
174,246
0.01% 607
2023
Q2
$1.25M Sell
174,246
-68,766
-28% -$401K ﹤0.01% 627
2023
Q1
$1.48M Sell
243,012
-7,040
-3% -$38.2K 0.01% 612
2022
Q4
$1.09M Sell
250,052
-623,665
-71% -$2.79M ﹤0.01% 656
2022
Q3
$3.42M Hold
873,717
0.02% 413
2022
Q2
$4.46M Sell
873,717
-1,479,016
-63% -$7.69M 0.02% 343
2022
Q1
$15.1M Buy
2,352,733
+129,244
+6% +$857K 0.05% 188
2021
Q4
$17.8M Buy
2,223,489
+25,511
+1% +$240K 0.07% 168
2021
Q3
$20.4M Buy
+2,197,978
New +$23M 0.08% 149

Other funds holding CLBT

CIBC Asset Management's CLBT Position: Q3 2024 in Review

CIBC Asset Management sold out of Cellebrite (CLBT) in Q3 2024, closing a stake of 122,620 shares — an estimated $1.47M sold.

CIBC Asset Management first reported a position in CLBT in Q3 2021 and held it in 12 quarters. The position peaked at $20.4M in Q3 2021. 164 funds tracked by Wall St. Rank hold CLBT as of Q3 2024.

  • CIBC Asset Management reported no remaining Cellebrite position as of Q3 2024 after selling out during the quarter.
  • CIBC Asset Management sold 122,620 Cellebrite shares in Q3 2024, an estimated $1.47M.
  • CIBC Asset Management first reported a position in Cellebrite in Q3 2021 and held it in 12 quarters.
  • CIBC Asset Management's Cellebrite position peaked at $20.4M in Q3 2021.
  • 164 funds tracked by Wall St. Rank held Cellebrite as of Q3 2024.

Based on CIBC Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.